Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance
Evidence from observational and in vitro studies suggests that insulin growth-factor-binding protein type 2 (IGFBP2) is a promising protein in non-communicable diseases, such as obesity, insulin resistance, metabolic syndrome, or type 2 diabetes. Accordingly, great efforts have been carried out to e...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/18239 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/18239 |
| Access Level: | acceso abierto |
| Palabra clave: | IGFBP2 Obesity Insulin resistance Lifestyle modification Epigenetic Proteína 2 de unión a factor de crecimiento similar a la insulina Obesidad Resistencia a la insulina Estilo de vida Epigénesis genética Diabetes Mellitus, Type 2 Humans Insulin-Like Growth Factor Binding Protein 2 Insulin Resistance Quality of Life Molecular Structure Exercise Diet |
| id |
ES_dfc510e412aaa5bf6f8281f71175d71f |
|---|---|
| oai_identifier_str |
oai:repisalud.isciii.es:20.500.12105/18239 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin ResistanceBoughanem, HatimYubero-Serrano, Elena M.López-Miranda, JoséTinahones, Francisco J.Macias-Gonzalez, ManuelIGFBP2ObesityInsulin resistanceLifestyle modificationEpigeneticProteína 2 de unión a factor de crecimiento similar a la insulinaObesidadResistencia a la insulinaEstilo de vidaEpigénesis genéticaDiabetes Mellitus, Type 2HumansInsulin-Like Growth Factor Binding Protein 2Insulin ResistanceObesityQuality of LifeMolecular StructureExerciseDietEvidence from observational and in vitro studies suggests that insulin growth-factor-binding protein type 2 (IGFBP2) is a promising protein in non-communicable diseases, such as obesity, insulin resistance, metabolic syndrome, or type 2 diabetes. Accordingly, great efforts have been carried out to explore the role of IGFBP2 in obesity state and insulin-related diseases, which it is typically found decreased. However, the physiological pathways have not been explored yet, and the relevance of IGFBP2 as an important pathway integrator of metabolic disorders is still unknown. Here, we review and discuss the molecular structure of IGFBP2 as the first element of regulating the expression of IGFBP2. We highlight an update of the association between low serum IGFBP2 and an increased risk of obesity, type 2 diabetes, metabolic syndrome, and low insulin sensitivity. We hypothesize mechanisms of IGFBP2 on the development of obesity and insulin resistance in an insulin-independent manner, which meant that could be evaluated as a therapeutic target. Finally, we cover the most interesting lifestyle modifications that regulate IGFBP2, since lifestyle factors (diet and/or physical activity) are associated with important variations in serum IGFBP2.Multidisciplinary Digital Publishing Institute (MDPI)[Boughanem,H; Tinahones,FJ; Macias-Gonzalez,M] Department of Endocrinology and Nutrition, Institute of Biomedical Research Institute in Malaga (IBIMA), Virgen de la Victoria University Hospital, Málaga, Spain. [Yubero-Serrano,EM; López-Miranda,J] Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. [Yubero-Serrano,EM; López-Miranda,J; Tinahones,FJ; Macias-Gonzalez,M] CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.20242024-02-1920212021-01-2420212021-01-24research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://hdl.handle.net/20.500.12105/18239reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/182392026-06-12T12:43:37Z |
| dc.title.none.fl_str_mv |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| title |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| spellingShingle |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance Boughanem, Hatim IGFBP2 Obesity Insulin resistance Lifestyle modification Epigenetic Proteína 2 de unión a factor de crecimiento similar a la insulina Obesidad Resistencia a la insulina Estilo de vida Epigénesis genética Diabetes Mellitus, Type 2 Humans Insulin-Like Growth Factor Binding Protein 2 Insulin Resistance Obesity Quality of Life Molecular Structure Exercise Diet |
| title_short |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| title_full |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| title_fullStr |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| title_full_unstemmed |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| title_sort |
Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance |
| dc.creator.none.fl_str_mv |
Boughanem, Hatim Yubero-Serrano, Elena M. López-Miranda, José Tinahones, Francisco J. Macias-Gonzalez, Manuel |
| author |
Boughanem, Hatim |
| author_facet |
Boughanem, Hatim Yubero-Serrano, Elena M. López-Miranda, José Tinahones, Francisco J. Macias-Gonzalez, Manuel |
| author_role |
author |
| author2 |
Yubero-Serrano, Elena M. López-Miranda, José Tinahones, Francisco J. Macias-Gonzalez, Manuel |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
[Boughanem,H; Tinahones,FJ; Macias-Gonzalez,M] Department of Endocrinology and Nutrition, Institute of Biomedical Research Institute in Malaga (IBIMA), Virgen de la Victoria University Hospital, Málaga, Spain. [Yubero-Serrano,EM; López-Miranda,J] Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. [Yubero-Serrano,EM; López-Miranda,J; Tinahones,FJ; Macias-Gonzalez,M] CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain. |
| dc.subject.none.fl_str_mv |
IGFBP2 Obesity Insulin resistance Lifestyle modification Epigenetic Proteína 2 de unión a factor de crecimiento similar a la insulina Obesidad Resistencia a la insulina Estilo de vida Epigénesis genética Diabetes Mellitus, Type 2 Humans Insulin-Like Growth Factor Binding Protein 2 Insulin Resistance Obesity Quality of Life Molecular Structure Exercise Diet |
| topic |
IGFBP2 Obesity Insulin resistance Lifestyle modification Epigenetic Proteína 2 de unión a factor de crecimiento similar a la insulina Obesidad Resistencia a la insulina Estilo de vida Epigénesis genética Diabetes Mellitus, Type 2 Humans Insulin-Like Growth Factor Binding Protein 2 Insulin Resistance Obesity Quality of Life Molecular Structure Exercise Diet |
| description |
Evidence from observational and in vitro studies suggests that insulin growth-factor-binding protein type 2 (IGFBP2) is a promising protein in non-communicable diseases, such as obesity, insulin resistance, metabolic syndrome, or type 2 diabetes. Accordingly, great efforts have been carried out to explore the role of IGFBP2 in obesity state and insulin-related diseases, which it is typically found decreased. However, the physiological pathways have not been explored yet, and the relevance of IGFBP2 as an important pathway integrator of metabolic disorders is still unknown. Here, we review and discuss the molecular structure of IGFBP2 as the first element of regulating the expression of IGFBP2. We highlight an update of the association between low serum IGFBP2 and an increased risk of obesity, type 2 diabetes, metabolic syndrome, and low insulin sensitivity. We hypothesize mechanisms of IGFBP2 on the development of obesity and insulin resistance in an insulin-independent manner, which meant that could be evaluated as a therapeutic target. Finally, we cover the most interesting lifestyle modifications that regulate IGFBP2, since lifestyle factors (diet and/or physical activity) are associated with important variations in serum IGFBP2. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2021-01-24 2021 2021-01-24 2024 2024-02-19 |
| dc.type.none.fl_str_mv |
research article http://purl.org/coar/resource_type/c_2df8fbb1 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12105/18239 |
| url |
http://hdl.handle.net/20.500.12105/18239 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
| publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
| dc.source.none.fl_str_mv |
reponame:Repisalud instname:Instituto de Salud Carlos III (ISCIII) |
| instname_str |
Instituto de Salud Carlos III (ISCIII) |
| reponame_str |
Repisalud |
| collection |
Repisalud |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869422094059569152 |
| score |
15,812455 |